Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2 [Phase 1, Phase 2]
This clinical trial update notes completion of Phase 1 and Phase 2 for a study assessing regulatory T cells in Type 1 Diabetes patients trea…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Incretin Effect and Use After Clinical Islet Transplantation [Phase 2]
Phase 2 trial results examining the incretin effect and its use after clinical islet transplantation in individuals with Type 1 diabetes.
-
FDA approval · 2015-06-16FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) submitted by Sanofi-Aventis U.S. LLC. This action indicat…
-
FDA approval · 2015-06-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, resulting in an additional regulatory action for this product.
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice
A completed clinical trial evaluated the safety of NovoPen 3 and FlexPen devices in routine clinical practice.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-06-12Clinical Trial Update: Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management [Phase 1, Phase 2]
A clinical trial evaluating ACT-based group self-management for Type 1 diabetes was withdrawn before completion, with no reported results.
-
FDA approval · 2015-06-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly (Humalog). This action typically relates to labeling changes o…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Coronary Artery Calcification in Type 1 Diabetes
A clinical trial studying coronary artery calcification in individuals with Type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3 [NA]
This clinical trial update reports that the study investigating mechanisms of hypoglycemia-associated autonomic dysfunction in type 1 diabet…
-
CLINICAL_TRIALS withdrawal · 2015-06-10Clinical Trial Update: The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia [NA]
A clinical trial examining whether antecedent hypoglycemia or exercise alters brain responses to later hypoglycemia in people with Type 1 di…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions [NA]
Clinical trial update describing a closed-loop approach for adults with sub-optimally controlled Type 1 diabetes under free-living condition…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)
This clinical trial update investigates markers of bone status in people with type 1 and type 2 diabetes, focusing on those with osteoporosi…
-
FDA approval · 2015-05-26FDA Approved: HUMALOG KWIKPEN — Original Application (Eli Lilly and Company)
The FDA approved Humalog KwikPen (insulin lispro) from Eli Lilly under an original application, enabling a rapid-acting insulin pen for bloo…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the clinical utility and safety of pramlintide in adults with Type 1 and Type 2 diabetes has completed. The update …
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Artificial Pancreas Control System in an Outpatient Setting [Phase 2]
The document reports results from a Phase 2 outpatient trial of an artificial pancreas control system for Type 1 diabetes. Results were post…
-
CLINICAL_TRIALS withdrawal · 2015-05-15Clinical Trial Update: Impaired Family Dynamics Leads to Non Compliance in Type I Diabetes
A pediatric-type 1 diabetes clinical trial was terminated; the update indicates noncompliance associated with impaired family dynamics.
-
CLINICAL_TRIALS withdrawal · 2015-05-15Clinical Trial Update: Insulin Resistance in Type I Diabetes in Pediatric Care
The pediatric trial investigating insulin resistance in Type 1 diabetes mellitus has been withdrawn (NCT00946426), sponsored by Nationwide C…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Effects of Low Intensity Aerobic Exercise on the Microvascular Endothelial Function of Patients With Type 1 Diabetes [NA]
A completed clinical trial evaluating the effect of low-intensity aerobic exercise on microvascular endothelial function in patients with Ty…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Diabetes Telemedicine Consultation: A Systems Improvement Intervention [NA]
This entry reports completion and posted results of a VA clinical trial evaluating diabetes telemedicine consultation as a systems-improveme…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin [Phase 2]
Phase 2 trial comparing a new formulation of insulin glargine with Lantus in adults with Type 1 Diabetes Mellitus on basal-plus mealtime ins…
-
CLINICAL_TRIALS research · 2015-05-07Clinical Trial Update: The Expert System VoiceDiab in Children With Diabetes [NA]
A clinical trial update for the Expert System VoiceDiab evaluating Type 1 diabetes mellitus in children, with the current status listed as u…
-
CLINICAL_TRIALS research · 2015-05-05Clinical Trial Update: Vascular Reactivity in Kidney Disease Patients [NA]
A completed clinical trial update on vascular reactivity in patients with chronic kidney disease and diabetes mellitus type 1 or type 2.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 Diabetes [Phase 2]
This update summarizes a Phase 2 trial evaluating an artificial pancreas closed-loop system for glucose control during exercise in adults wi…
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes [Phase 2]
A Phase 2 trial evaluating a closed-loop insulin delivery system (artificial pancreas) for 60 hours in adults with Type 1 diabetes completed…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)
A completed clinical trial evaluated the use of methylation-specific PCR to detect human beta cell death in Type 1 Diabetes Mellitus. The st…